Acorn Capital Advisors LLC Invests $8.24 Million in Trevi Therapeutics, Inc. (NASDAQ:TRVI)
MarketBeat
Acorn Capital Advisors LLC acquired a new stake in Trevi Therapeutics, Inc. (NASDAQ:TRVI - Free Report) in the 4th quarter, according to its most recent disclosure with the SEC. The fund acquired 2,001,048 shares of the company's stock, valued at approximately $8,244,000. Trevi Therapeutics makes u
NASDAQ:TRVI